IPG Photonics Corp

IPG Photonics Corp(IPGP)のニュースとイベント

$76.530

-0.712 (-0.93%)終値時点

IPGP のニュース

IPGP のイベント

8/4 09:31

IPG Photonics Q2 Revenue at $278.58M, Slightly Below Expectations

Reports Q2 revenue $278.58M, consensus $279.97M. "We delivered our third consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance and adjusted gross margin and adjusted EPS above our expectations," said Mark Gitin, Chief Executive Officer of IPG Photonics. "Industrial Solutions generated strong revenue growth, supported by robust demand and disciplined execution across different markets and applications, particularly in battery manufacturing. Advanced Solutions revenue benefited from our continued focus on key strategic initiatives, resulting in strong sales growth in semiconductor applications. We see continued interest in our CROSSBOW directed energy system. Additionally, our recently announced acquisition of Lumibird Medical will further accelerate our strategic expansion into attractive medical markets in Advanced Solutions."

8/4 09:30

Company Sees Q3 Revenue of $265M to $295M

Sees Q3 revenue $265M-$295M, consensus $276.6M. "Our book-to-bill remained above one in the second quarter, pointing to ongoing robust demand for our solutions and the team's focused execution of our growth strategy. Our technological leadership in lasers and photonics and proven track record of solving challenging customer problems continues to create compelling opportunities for laser adoption in attractive markets and applications. Supported by the One IPG Operating Model, which drives operational excellence, and an innovation engine, we are unlocking areas of significant additional and lasting value for our customers and stockholders," concluded Gitin.

7/16 18:30

IPG Photonics to Acquire Lumibird Medical for €300M

IPG Photonics has entered into a binding offer to acquire Lumibird Medical. The transaction is expected to deliver financial benefits by adding a high-margin business that is accretive to gross margin, EBITDA and adjusted EPS. IPG believes that the combined medical businesses will create a scaled medical laser platform for growth with complementary established leadership in ophthalmology and urology. The company expects that this also adds approximately $1B in addressable market for Advanced Solutions. IPG intends to acquire Lumibird Medical for a purchase price of EUR300M on a cash-free, debt-free basis. The purchase price will be paid in cash at closing. A contingent earnout consideration of up to EUR50M additional in cash is based on achieving certain 2026 and 2027 performance metrics. The acquisition will be funded with cash on hand.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める